Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonMark Ainsworth, Christopher J. Groves, Abbie Bown et al.|The Lancet Infectious Diseases|2020Cited by 405
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Hal Drakesmith, Zhichao Ai et al.|Cell|2022Cited by 327
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19Christos P. Kotanidis, Moustafa Attar, Cheng Xie et al.|The Lancet Digital Health|2022Cited by 41
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Susanna Dunachie, Zhichao Ai et al.|medRxiv|2021Cited by 35
Long COVID research: an update from the PHOSP-COVID Scientific SummitChristopher E. Brightling, Mark Ainsworth, Rachael A Evans et al.|The Lancet Respiratory Medicine|2023Cited by 12